The Influence of Nordic Walking Training on the Serum Levels of Sirtuins, FOXO3a, and Vitamin D Metabolites in Patients with Multiple Myeloma
- PMID: 39727710
- PMCID: PMC11674275
- DOI: 10.3390/curroncol31120587
The Influence of Nordic Walking Training on the Serum Levels of Sirtuins, FOXO3a, and Vitamin D Metabolites in Patients with Multiple Myeloma
Abstract
Background: Multiple myeloma, a malignancy of plasma cells, often involves the disruption of vitamin D metabolism. Vitamin D, acting through its receptor (VDR), affects transcription factors like FOXO and sirtuins, which regulate cellular processes. The impact of physical activity on these markers in multiple myeloma patients is unclear. Therefore, the objective of this study was to evaluate the effects of a 6-week training program on these parameters.
Material and methods: The study was completed by 30 patients, including 16 in the Nordic walking training group (TG) and 14 in the control group (non-exercising, CG). All participants underwent a thorough medical interview before starting the project. Venous blood samples were collected from all participants four times-at baseline, after 3 weeks, after 6 weeks, and after 9 weeks (follow-up). The serum concentrations of sirtuin 1, sirtuin 3, Foxo3a, vitamin D receptor (VDR), 25(OH)D3, and 1,25(OH)2D were determined. Body composition, physical fitness, and physical activity level were assessed at baseline and after 6 weeks.
Results: No statistically significant changes were observed in the serum levels of sirtuins, the FOXO3a protein, and 1,25(OH)2D. A statistically significant difference was observed in the levels of VDR for both time and group factors, but this was not confirmed in the post hoc test. Vitamin 25(OH)D3 level increased significantly in the study group with time.
Conclusions: The applied 6-week Nordic walking training cycle positively affected the level of vitamin 25(OH)D3 but did not influence the rest of the biochemical parameters studied. The obtained results also indicate that the applied intervention is safe for patients and does not interfere with body composition.
Keywords: FOXO3a; multiple myeloma; nordic walking; physical activity; sirtuins; vitamin D metabolites.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Effect of a 6-Week Cycle of Nordic Walking Training on Vitamin 25(OH)D3, Calcium-Phosphate Metabolism and Muscle Damage in Multiple Myeloma Patients-Randomized Controlled Trial.J Clin Med. 2022 Nov 3;11(21):6534. doi: 10.3390/jcm11216534. J Clin Med. 2022. PMID: 36362762 Free PMC article.
-
Effects of a 6-week Nordic walking training on changes in 25(OH)D blood concentration in women aged over 55.J Sports Med Phys Fitness. 2017 Jan-Feb;57(1-2):124-129. doi: 10.23736/S0022-4707.16.05964-X. Epub 2016 Jan 20. J Sports Med Phys Fitness. 2017. PMID: 26853237
-
The Effect of a Six-Week Nordic Walking Training Cycle on Oxidative Damage of Macromolecules and Iron Metabolism in Older Patients with Multiple Myeloma in Remission-Randomized Clinical Trial.Int J Mol Sci. 2023 Oct 19;24(20):15358. doi: 10.3390/ijms242015358. Int J Mol Sci. 2023. PMID: 37895038 Free PMC article. Clinical Trial.
-
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.PLoS Med. 2007 Mar;4(3):e103. doi: 10.1371/journal.pmed.0040103. PLoS Med. 2007. PMID: 17388667 Free PMC article. Clinical Trial.
-
Vitamin D and systemic cancer: is this relevant to malignant melanoma?Br J Dermatol. 2002 Aug;147(2):197-213. doi: 10.1046/j.1365-2133.2002.04960.x. Br J Dermatol. 2002. PMID: 12174089 Review.
References
-
- Wojciechowska U., Barańska K., Miklewska M., Didkowska J.A. Cancer Incidence and Mortality in Poland in 2020. Nowotw. J. Oncol. 2023;73:129–145. doi: 10.5603/NJO.2023.0026. - DOI
-
- Giannopoulos K., Jamroziak K., Usnarska-Zubkiewicz L., Dytfeld D., Jurczyszyn A., Walewski J., Lech-Marańda E., Walter-Croneck A., Pieńkowska-Grela B., Wróbel T., et al. Zalecenia Polskiej Grupy Szpiczakowej Dotyczące Rozpoznawania i Leczenia Szpiczaka Plazmocytowego Oraz Innych Dyskrazji Plazmocytowych Na Rok 2021. Polska Grupa Szpiczakowa; Poland: 2020.
-
- Witamina D—Od Dawnego Czynnika Przeciwkrzywiczego Do Nowej Substancji o Działaniu Plejotropowym Vitamin D—From the Past Antirachitic Factor to New Pleiotropic Substance. [(accessed on 1 November 2024)]. Available online: https://ppm.edu.pl/info/article/UMBe5f8bd0b9624473fbb6858d0c4b50d62?aq=m....
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous